510(k) Report

510(k) · Cleared

Cleared

Coamate (R) Antithrombin Chromogenic Assay

K915083510(k) TraditionalCleared Jan 3, 199252-day reviewClass II21 CFR 864.7060

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Kabi Pharmacia, Inc. · JBQ Antithrombin Iii Quantitation

Cleared on Jan 3, 1992 after a 52-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 11 later devices descend from it.

Decided
Jan 3, 1992
Review
52 days
Class
Class II
Product code
JBQ
Recalls
None
Predicates
0

11 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2005: 2 descendants cleared1998: 1 descendant cleared2007: 1 descendant cleared2000: 1 descendant cleared2002: 2 descendants cleared2004: 1 descendant cleared2003: 1 descendant cleared2006: 1 descendant cleared2018: 1 descendant cleared1990200020102020
  1. This deviceK915083 Coamate (R) Antithrombin Chromogenic AssayKabi Pharmacia, Inc. · 1992
  2. Descendant · cites it directly · 9 of its ownK980499 IL Test AntithrombinInstrumentation Laboratory CO · 1998
  3. Descendant · 2 generations on · 4 of its ownK994238 IL Test Liquid AntithrombinInstrumentation Laboratory CO · 2000
  4. Descendant · 2 generations on · 2 of its ownK033775 Hemosil Liquid Antithrombin XLInstrumentation Laboratory CO · 2004
  5. Descendant · 2 generations on · 2 of its ownK022195 Coamatic at-400Instrumentation Laboratory CO · 2002
  6. Descendant · 3 generations on · 1 of its ownK062431 Hemosil Liquid AntithrombinInstrumentation Laboratory CO · 2006

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

1998: 12000: 12002: 22003: 12004: 12005: 22006: 12007: 12018: 1
1998high 2 (2002) · low 0 (1999)2026

Most influential descendants

Showing 5 of 11 · See all
  • K980499IL Test AntithrombinInstrumentation Laboratory CO · 1998 · cites it directly9descendants
  • K994238IL Test Liquid AntithrombinInstrumentation Laboratory CO · 2000 · 2 generations on4descendants
  • K033775Hemosil Liquid Antithrombin XLInstrumentation Laboratory CO · 2004 · 2 generations on2descendants
  • K022195Coamatic at-400Instrumentation Laboratory CO · 2002 · 2 generations on2descendants
  • K062431Hemosil Liquid AntithrombinInstrumentation Laboratory CO · 2006 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K915083Coamate (R) Antithrombin Chromogenic AssayKabi Pharmacia, Inc.1992—
+1K980499IL Test AntithrombinInstrumentation Laboratory CO1998—
+2K994238IL Test Liquid AntithrombinInstrumentation Laboratory CO2000—
+2K033775Hemosil Liquid Antithrombin XLInstrumentation Laboratory CO2004—
+2K022195Coamatic at-400Instrumentation Laboratory CO2002—
+3K062431Hemosil Liquid AntithrombinInstrumentation Laboratory CO2006—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199810
200010
200220
200310
200410
200520
200610
200710
201810
FIG. 1 — Lineage of K915083, 1992–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JBQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JBQ device

  1. #1 K242952 INNOVANCE Antithrombinscore 9.1 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (11)

See all 11

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K980499IL Test AntithrombinInstrumentation Laboratory CO19989
K043007Biophen Antithrombin 2.5, Reference # 221102; Biophen Antithrombin 5, Reference # 221105Hyphen Biomed20050

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K980499 (Instrumentation Laboratory CO, 1998) has gone furthest, with 9 descendants of its own.

How does its category compare?

All JBQ devices

JBQ Antithrombin Iii Quantitation: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JBQ

1in 2025

2007: 12009: 12025: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JBQ

Too few JBQ 510(k)s in any year since 2007 to give a median.

Recalls per year · JBQ

No recall names JBQ since 2007.

Adverse event reports per year · JBQ

1in 2023

2013: 12022: 12023: 1
2007high 1 (2013) · low 0 (2007)2025

MAUDE reports naming product code JBQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20100—00
20110—00
20120—00
20130—01
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—01
20230—01
20240—00
20251—00
20260—0—
Cite this page

510(k) Report. “K915083: Coamate (R) Antithrombin Chromogenic Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K915083

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026